A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

The research group led by Prof. Wang Chu from the College of Chemistry and Molecular Engineering at Peking University ...

Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...

Using a novel quantitative chemoproteomic strategy, a research group led by Prof. Wang Chu from the College of Chemistry and ...

A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Tau is a protein that clumps together and forms "tangles" in the brains of people who have Alzheimer’s, per Healthline. These tangles interfere with cognitive function. Tau tangles typically ...

Using a novel quantitative chemoproteomic strategy, the team uncovered a protective role of dopamine (DA) in regulating the function of the microtubule-associated protein Tau. This discovery ...

people’s brain function is already declining. The scans are also expensive and not available at all hospitals. More sensitive ways to detect amyloid and tau, another protein related to the ...

Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...

A research team at the University of Cologne has made a significant breakthrough in understanding the role of the tau protein in ... that restrict normal cell function or even cause the cell ...